Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
This study will use a two-part, multicenter, dose-titration study in pediatric patients with a detrusor overactivity associated with a neurological condition
Age
3–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
3 years to \< 17 years
Neurogenic bladder
Neurological condition
CIC
You may not be if
Have anatomical bladder abnormalities
Sensitivity to anticholinergics
Bladder augmentation
Clareo Health | Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
